Skip to main content

Table 2 Quality assessment of the included studies based on the NOS checklist (adapted for cross sectional studies)

From: Serum and plasma levels of brain-derived neurotrophic factor in individuals with eating disorders (EDs): a systematic review and meta-analysis

Author, Year

QUESTION 1

QUESTION 2

QUESTION 3

QUESTION 4

QUESTION 5

QUESTION 6

QUESTION 7

Overall

Nakazato et al., 2002

*

*

*

**

 

*

*

7

Nakazato et al., 2006

 

*

*

**

*

*

 

6

Nakazato et al., 2009

*

*

*

**

*

 

*

7

Yamada et al., 2012

*

 

*

 

*

*

*

5

Dmitrzak-Weglarz et al., 2013

*

*

*

**

*

*

 

7

Zwipp et al., 2014

*

*

 

*

*

*

*

6

Eddy et al., 2015

*

*

*

 

**

*

*

7

Homan et al., 2015

*

 

*

**

*

 

*

6

Rybakowski et al., 2017

*

*

*

*

**

 

*

7

Matsumoto et al., 2017

*

*

*

**

 

*

*

7

Mancuso et al., 2020

*

*

*

**

*

 

*

7

Tyszkiewicz-Nwafor et al., 2020

*

*

*

*

*

 

*

6

Borsdorf et al., 2021

*

*

*

*

**

*

*

8

Keeler et al., 2022

*

*

 

*

**

 

*

6

  1. Selection: Questions 1 to 4, Comparability: Question 5, Outcome: Questions 6 and 7
  2. *, ** The NOS checklist uses a "star system" to assess the quality of studies, with the number of stars indicating the overall score in that particular domain, i.e., Selection, Comparability, and Outcome